DPC Biosciences Corporation (“DPC” or the “Corporation”) (NEX:DPC.H), a company that has been fundamentally inactive since 2001 and which is currently listed on NEX, is pleased to announce that it will be seeking regulatory approval and the approval of its shareholders to reactivate (the “Reactivation”) on the TSX Venture Exchange (the “Exchange”).
